The advisor forum answers questions about addressing code status, low immunoglobulin levels, radioimmunotherapy, and more.
Features
How do you foster hope in cancer patients, especially when they are terminally ill? For the author, the first step is open communication.
This month’s questions: retreating with rituximab after an allergic reaction and administering the new prostate cancer immunotherapy.
CSTDs will promote safer administration of chemotherapy drugs.
Cancer-related fatigue can continue to be a significant problem for patients, even long after they have completed treatment.
Recent advances in the timing and targeting of radiation therapy promise to help minimize the collateral damage radiotherapy inflicts on healthy tissues — trends that were on display at the second European Lung Cancer Conference.
Cancer-related fatigue is widespread, but attention to the cause can often help to alleviate the problem.
Pain management is important for cancer patients during therapy and sometimes after treatment is completed—not just at the end of life.
The author describes how she learned to stop and listen and clarify when a patient asks a difficult question.
The advisor forum answers questions about anemia, nurse navigators, chemotherapy-associated rashes, and more.
- Loading...
